4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001140361-13-046709
CIK 0001069308operating
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 3:55 PM ET
Size
16.7 KB
Accession
0001140361-13-046709
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Purchase
Common Stock
2013-12-18$1.70/sh+8,000$13,600→ 58,000 total
Footnotes (1)
- [F1]Purchased in an underwritten public offering which is expected to close on December 23, 2013.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 3:55 PM ET
- Size
- 16.7 KB